1. Home
  2. CGC vs NPCE Comparison

CGC vs NPCE Comparison

Compare CGC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

HOLD

Current Price

$1.38

Market Cap

404.3M

Sector

Health Care

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.94

Market Cap

432.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGC
NPCE
Founded
N/A
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.3M
432.3M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
CGC
NPCE
Price
$1.38
$16.94
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
8.3M
145.7K
Earning Date
05-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
36.75
29.03
EPS
N/A
N/A
Revenue
$12,759,000.00
$99,986,000.00
Revenue This Year
$8.27
$0.90
Revenue Next Year
$15.68
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$0.84
$7.56
52 Week High
$2.38
$18.97

Technical Indicators

Market Signals
Indicator
CGC
NPCE
Relative Strength Index (RSI) 74.31 71.40
Support Level $1.30 $15.25
Resistance Level $1.78 $16.96
Average True Range (ATR) 0.09 0.68
MACD 0.03 0.27
Stochastic Oscillator 83.32 85.94

Price Performance

Historical Comparison
CGC
NPCE

About CGC Canopy Growth Corporation

Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: